FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

17636311000001104: Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Aug 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
61263701000001111 Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
92724301000001114 Tyverb 250mg tablets (Novartis Pharmaceuticals UK Ltd) 84 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Is a Lapatinib 250mg tablets 84 tablet true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has AMP Tyverb 250mg tablets (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has specific active ingredient Lapatinib ditosylate monohydrate false Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has specific active ingredient Lapatinib ditosylate monohydrate true Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lapatinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start